Natural killer cells modulation in hematological malignancies.
Ontology highlight
ABSTRACT: Hematological malignancies (HM) treatment improved over the last years resulting in increased achievement of complete or partial remission, but unfortunately high relapse rates are still observed, due to remaining minimal residual disease. Therefore, sustainment of long-term remission is crucial, using either drug maintenance treatment or by boosting or prolonging an immune response. Immune system has a key role in tumor surveillance. Nonetheless, tumor-cells evade the specific T-lymphocyte mediated immune surveillance using many mechanisms but especially by the down-regulation of the expression of HLA class I antigens. In theory, these tumor-cells lacking normal expression of HLA class I molecules should be destroyed by natural killer (NK) cells, according to the missing-self hypothesis.
SUBMITTER: Baier C
PROVIDER: S-EPMC3867693 | biostudies-literature | 2013 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA